Mmadili N Ilozumba1, Ting-Yuan D Cheng1, Marian L Neuhouser2, Joshua W Miller3, Shirley A A Beresford2,4, David J Duggan5, Adetunji T Toriola6, Xiaoling Song2, Yingye Zheng2, Lynn B Bailey7, Aladdin H Shadyab8, Simin Liu9,10, Olga Malysheva11, Marie A Caudill11, Cornelia M Ulrich12,13. 1. Department of Epidemiology, University of Florida, Gainesville, FL, USA. 2. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. 3. Department of Nutritional Sciences, Rutgers University, New Brunswick, NJ, USA. 4. Department of Epidemiology, University of Washington, Seattle, WA, USA. 5. Translational Genomics Research Institute, Phoenix, AZ, USA. 6. Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA. 7. Department of Foods and Nutrition, University of Georgia, Athens, GA, USA. 8. Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, CA, USA. 9. Department of Epidemiology, Brown University, Providence, RI, USA. 10. Department of Medicine, Brown University, Providence, RI, USA. 11. Division of Nutritional Sciences, Cornell University, Ithaca, NY, USA. 12. Huntsman Cancer Institute, Salt Lake City, UT, USA. 13. Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA.
Abstract
BACKGROUND: Choline plays an integral role in one-carbon metabolism in the body, but it is unclear whether genetic polymorphisms are associated with variations in plasma choline and its metabolites. OBJECTIVES: This study aimed to evaluate the association of genetic variants in choline and one-carbon metabolism with plasma choline and its metabolites. METHODS: We analyzed data from 1423 postmenopausal women in a case-control study nested within the Women's Health Initiative Observational Study. Plasma concentrations of choline, betaine, dimethylglycine (DMG), and trimethylamine N-oxide were determined in 12-h fasting blood samples collected at baseline (1993-1998). Candidate and tagging single-nucleotide polymorphisms (SNPs) were genotyped in betaine-homocysteine S-methyltransferase (BHMT), BHMT2, 5,10-methylenetetrahydrofolate reductase (MTHFR), methylenetetrahydrofolate dehydrogenase (NADP+ dependent 1) (MTHFD1), 5-methyltetrahydrofolate-homocysteine methyltransferase (MTR), and 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR). Linear regression was used to derive percentage difference in plasma concentrations per variant allele, adjusting for confounders, including B-vitamin biomarkers. Potential effect modification by plasma vitamin B-12, vitamin B-6, and folate concentrations and folic-acid fortification periods was examined. RESULTS: The candidate SNP BHMT R239Q (rs3733890) was associated with lower concentrations of plasma betaine and DMG concentrations (-4.00% and -6.75% per variant allele, respectively; both nominal P < 0.05). Another candidate SNP, BHMT2 rs626105 A>G, was associated with higher plasma DMG concentration (13.0%; P < 0.0001). Several tagSNPs in these 2 genes were associated with plasma concentrations after correction for multiple comparisons. Vitamin B-12 status was a significant effect modifier of the association between the genetic variant BHMT2 rs626105 A>G and plasma DMG concentration. CONCLUSIONS: Genetic variations in metabolic enzymes were associated with plasma concentrations of choline and its metabolites. Our findings contribute to the knowledge on the variation in blood nutrient concentrations in postmenopausal women.
BACKGROUND:Choline plays an integral role in one-carbon metabolism in the body, but it is unclear whether genetic polymorphisms are associated with variations in plasma choline and its metabolites. OBJECTIVES: This study aimed to evaluate the association of genetic variants in choline and one-carbon metabolism with plasma choline and its metabolites. METHODS: We analyzed data from 1423 postmenopausal women in a case-control study nested within the Women's Health Initiative Observational Study. Plasma concentrations of choline, betaine, dimethylglycine (DMG), and trimethylamine N-oxide were determined in 12-h fasting blood samples collected at baseline (1993-1998). Candidate and tagging single-nucleotide polymorphisms (SNPs) were genotyped in betaine-homocysteine S-methyltransferase (BHMT), BHMT2, 5,10-methylenetetrahydrofolate reductase (MTHFR), methylenetetrahydrofolate dehydrogenase (NADP+ dependent 1) (MTHFD1), 5-methyltetrahydrofolate-homocysteine methyltransferase (MTR), and 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR). Linear regression was used to derive percentage difference in plasma concentrations per variant allele, adjusting for confounders, including B-vitamin biomarkers. Potential effect modification by plasma vitamin B-12, vitamin B-6, and folate concentrations and folic-acid fortification periods was examined. RESULTS: The candidate SNP BHMTR239Q (rs3733890) was associated with lower concentrations of plasma betaine and DMG concentrations (-4.00% and -6.75% per variant allele, respectively; both nominal P < 0.05). Another candidate SNP, BHMT2rs626105 A>G, was associated with higher plasma DMG concentration (13.0%; P < 0.0001). Several tagSNPs in these 2 genes were associated with plasma concentrations after correction for multiple comparisons. Vitamin B-12 status was a significant effect modifier of the association between the genetic variant BHMT2rs626105 A>G and plasma DMG concentration. CONCLUSIONS: Genetic variations in metabolic enzymes were associated with plasma concentrations of choline and its metabolites. Our findings contribute to the knowledge on the variation in blood nutrient concentrations in postmenopausal women.
Authors: Sajin Bae; Cornelia M Ulrich; Marian L Neuhouser; Olga Malysheva; Lynn B Bailey; Liren Xiao; Elissa C Brown; Kara L Cushing-Haugen; Yingye Zheng; Ting-Yuan David Cheng; Joshua W Miller; Ralph Green; Dorothy S Lane; Shirley A A Beresford; Marie A Caudill Journal: Cancer Res Date: 2014-10-21 Impact factor: 12.701
Authors: Ase Fredriksen; Klaus Meyer; Per Magne Ueland; Stein Emil Vollset; Tom Grotmol; Jørn Schneede Journal: Hum Mutat Date: 2007-09 Impact factor: 4.878
Authors: Jian Yan; Xinyin Jiang; Allyson A West; Cydne A Perry; Olga V Malysheva; Srisatish Devapatla; Eva Pressman; Francoise Vermeylen; Sally P Stabler; Robert H Allen; Marie A Caudill Journal: Am J Clin Nutr Date: 2012-03-14 Impact factor: 7.045
Authors: Martin Kohlmeier; Kerry-Ann da Costa; Leslie M Fischer; Steven H Zeisel Journal: Proc Natl Acad Sci U S A Date: 2005-10-18 Impact factor: 11.205
Authors: Silvina F Choumenkovitch; Jacob Selhub; Peter W F Wilson; Jeanne I Rader; Irwin H Rosenberg; Paul F Jacques Journal: J Nutr Date: 2002-09 Impact factor: 4.798
Authors: Irene Pusceddu; Markus Herrmann; Susanne H Kirsch; Christian Werner; Ulrich Hübner; Marion Bodis; Ulrich Laufs; Thomas Widmann; Stefan Wagenpfeil; Jürgen Geisel; Wolfgang Herrmann Journal: Eur J Nutr Date: 2016-07-05 Impact factor: 5.614
Authors: Clare Abbenhardt; Joshua W Miller; Xiaoling Song; Elissa C Brown; Ting-Yuan David Cheng; Mark H Wener; Yingye Zheng; Adetunji T Toriola; Marian L Neuhouser; Shirley A A Beresford; Karen W Makar; Lynn B Bailey; David R Maneval; Ralph Green; Joann E Manson; Linda Van Horn; Cornelia M Ulrich Journal: J Nutr Date: 2014-03-19 Impact factor: 4.798
Authors: Jaana A Hartiala; W H Wilson Tang; Zeneng Wang; Amanda L Crow; Alexandre F R Stewart; Robert Roberts; Ruth McPherson; Jeanette Erdmann; Christina Willenborg; Stanley L Hazen; Hooman Allayee Journal: Nat Commun Date: 2016-01-29 Impact factor: 14.919
Authors: Karen E Christensen; Olga V Malysheva; Stephanie Carlin; Fernando Matias; Amanda J MacFarlane; René L Jacobs; Marie A Caudill; Rima Rozen Journal: Nutrients Date: 2021-12-28 Impact factor: 5.717
Authors: Emily S Krueger; Joseph L Beales; Kacie B Russon; Weston S Elison; Jordan R Davis; Jackson M Hansen; Andrew P Neilson; Jason M Hansen; Jeffery S Tessem Journal: Biomolecules Date: 2021-12-17